Key result
Treatment with corticosteroids, hydroxychloroquine, mycophenolate mofetil, and anti-heart failure medications led to dramatic symptom responses in the first few weeks.
Why the study?
Myocarditis is an uncommon manifestation of systemic lupus erythematosus that can range from subclinical to life-threatening, making early recognition and treatment critical.
Does treatment with steroids, hydroxychloroquine, and mycophenolate mofetil improve symptoms in patients with lupus myocarditis?
Case Report (n=2)
Does treatment with steroids, hydroxychloroquine, and mycophenolate mofetil improve symptoms in patients with lupus myocarditis?
Early recognition and treatment of lupus myocarditis with immunosuppressants and heart failure medications can lead to dramatic symptom improvement.
Answers are grounded in this paper and cite their sources.
Consider SLE in unexplained myocarditis; hypothesis-generating for prevalence and optimal management.
BACKGROUND: Myocarditis is an uncommon manifestation of systemic lupus erythematosus in which the clinical presentation can range from subclinical to life-threatening. We report cases of two patients who presented to our hospital with myocarditis as an initial manifestation of systemic lupus erythematosus despite negative results of extensive workup that excluded other diagnoses. The mainstays of treatment are corticosteroids, immunosuppressive agents, and anti-heart failure medications, with use of the latter being case-specific. Mycophenolate mofetil was the cornerstone of the proposed treatment for induction of remission, although it is well known to be used as a maintenance therapy in lupus myocarditis. CASE PRESENTATION: Both Emirati patients described satisfied the diagnostic criteria for mixed connective tissue disease (systemic lupus predominant) and systemic lupus erythematous. Other differential diagnoses of myocarditis were excluded. The patients were started on pulsed steroid followed by oral steroid, with hydroxychloroquine, mycophenolate mofetil, and anti-heart failure medications used as needed. Dramatic responses were noted in the first few weeks in terms of symptoms. CONCLUSION: Early recognition and treatment of lupus myocarditis is needed to avoid fatal consequences.
No takes yet. Share an insight, caveat, or question.
Al-Nokhatha et al. (2019) conducted a case report in Systemic lupus erythematosus with myocarditis (n=2). Corticosteroids, hydroxychloroquine, mycophenolate mofetil, and anti-heart failure medications was evaluated on Symptom response. Treatment with corticosteroids, hydroxychloroquine, mycophenolate mofetil, and anti-heart failure medications led to dramatic symptom responses in the first few weeks.
Synapse has enriched 10 related papers. Consider them for comparative context: